sb 202190 has been researched along with Hyperglycemia in 4 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Hyperglycemia: Abnormally high BLOOD GLUCOSE level.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, SW | 1 |
Kim, CE | 1 |
Kim, MH | 1 |
Devaraj, S | 1 |
Venugopal, SK | 1 |
Singh, U | 1 |
Jialal, I | 1 |
Wenzel, S | 1 |
Soltanpour, G | 1 |
Schlüter, KD | 1 |
Guha, M | 1 |
Bai, W | 1 |
Nadler, JL | 1 |
Natarajan, R | 1 |
4 other studies available for sb 202190 and Hyperglycemia
Article | Year |
---|---|
Flavonoids inhibit high glucose-induced up-regulation of ICAM-1 via the p38 MAPK pathway in human vein endothelial cells.
Topics: Anthracenes; Butadienes; Cells, Cultured; Endothelium, Vascular; Enzyme Inhibitors; Flavanones; Gluc | 2011 |
Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}.
Topics: Cell Line; Enzyme Induction; Enzyme Inhibitors; Flavonoids; Humans; Hyperglycemia; Imidazoles; Inter | 2005 |
No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function.
Topics: Animals; Antioxidants; Ascorbic Acid; Cells, Cultured; Diabetes Mellitus; Electrophysiology; Glucose | 2005 |
Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways.
Topics: Acetylcysteine; Cell Line; Gene Expression Regulation; Glucose; Humans; Hyperglycemia; Imidazoles; L | 2000 |